The annual seasonal malaria chemoprevention campaign (SMC) spearheaded by the Malaria Consortium has begun with a target of reaching 5.5m children in Nigeria, Chad and Burkina Faso who are at risk of contracting or succumbing to the disease.
Any mobile electronic device – from a phone to an environmental sensor – requires a power supply. And while modern batteries are sophisticated, they are not infallible. Who, for instance, can say that their phone has never died on them?
Canadian biopharma services company Altasciences has appointed Lynne LeSauteur as VP, immunochemistry and immunology. LeSauteur, who joins the company from the Human Health Therapeutics Research Center at the National Research Council of Canada (NRC), will be responsible for the bioanalytical services department in the US and the ligand binding team in Canada.
A ‘living’ polymerisation has no termination step in the absence of impurities. Living ionic polymerisations, in particular, are very powerful tools for making polymeric materials with precisely controlled molecular weight and a narrow polydispersity. Controlled polymerisations are closely related and ‘almost living’, that is termination is unlikely but can still happen – usually at high conversion when monomer molecules become scarce.
When most people imagine a farmer they picture an individual at the wheel of a tractor or out tending cattle. What they may not be aware of is the great technological changes that have happened over the last five years. Tractors can steer themselves, decisions about crop treatments are based on drone imagery of the fields and machine vision is being used to direct robotic harvesters.
Pharma major AstraZeneca, headquartered in Cambridge, UK, has amended its collaboration agreement with US pharmaceutical company Ironwood Pharmaceuticals. AstraZeneca now has sole responsibility for the R&D, manufacture and commercialisation of the irritable bowel syndrome (IBS) treatment Linzess in mainland China, Hong Kong and Macau.
